Breaking News Instant updates and real-time market news.

BMRN

BioMarin

$91.86

1.98 (2.20%)

04:55
04/16/19
04/16
04:55
04/16/19
04:55

BioMarin management to meet with Piper Jaffray

Dinner Meeting with management to be held in San Francisco on April 16 hosted by Piper Jaffray.

  • 16

    Apr

  • 25

    Apr

BMRN BioMarin
$91.86

1.98 (2.20%)

02/25/19
RHCO
02/25/19
NO CHANGE
Target $117
RHCO
Buy
BioMarin price target lowered to $117 from $126 at SunTrust
SunTrust analyst Edward Nash lowered his price target on BioMarin to $117 after its "tough Q4 and less inspiring 2019 guidance", saying all of the company's products except for Palynziq performed worse than expected. The analyst cites Latin America seasonal ordering patterns among the likely culprits, adding that the next potential catalyst for BioMarin - the June release of Phase I/II Study of Valrox - could also see a "downward trend of Factor VIII activity levels." Nash keeps his Buy rating on the shares longer term, stating that BioMarin's R&D competencies and a "strong sales force in Orphan markets will continue to provide strong revenue growth and durable barriers to entry".
02/25/19
FBCO
02/25/19
NO CHANGE
Target $47
FBCO
Neutral
Roche may spark another bull run for gene therapy names, says Credit Suisse
Credit Suisse analyst Martin Auster notes that the Wall Street Journal recently reported that Roche (RHHBY) is nearing a deal with Spark Therapeutics (ONCE) for $5B. The analyst believes the transaction value implies the re-emergence of Spark's hemophilia A gene therapy program with a competitive profile and substantial value assigned to additional pipeline programs, such as SPK-3006 for Pompe, and the technology platform. Spark's acquisition would further strengthen the company's position in the hemophilia space, he contends. Further, Auster argues that the deal may increase M&A interest among other gene therapy names in his coverage universe, which include BioMarin (BMRN), Sarepta (SRPT), Ultragenyx (RARE), PTC (PTC) and Solid Biosciences (SLDB). He sees particularly strong read-through to Sarepta. The analyst reiterates a Neutral rating and a $47 price target on Spark's shares.
03/04/19
CANT
03/04/19
NO CHANGE
Target $131
CANT
Overweight
BioMarin price target raised to $131 from $126 at Cantor Fitzgerald
Cantor Fitzgerald analyst Eliana Merle raised her price target for BioMarin Pharmaceutical to $131 to reflect Friday's positive Committee for Medicinal Products for Human Use opinion on Palynziq. The analyst thinks the approval is supportive of base business revenue growth, and she models worldwide Palynziq sales of $900M. She keeps an Overweight rating on BioMarin.
04/09/19
RAJA
04/09/19
INITIATION
RAJA
Outperform
BioMarin resumed with an Outperform at Raymond James
Raymond James analyst Reni Benjamin resumed coverage on BioMarin with an Outperform and $110 price target. The analyst said baseline ultra-orphan business is on tract to generate $2.1B by 2024, key read-outs are expected in mid-2019 for its leading Hemophilia A gene therapy asset, and the current pipeline of seven revenue generating products, which could become nine by 2020, are modeled to generate $3.3B in sales by 2024.

TODAY'S FREE FLY STORIES

CPRI

Capri Holdings

$44.85

-1.26 (-2.73%)

14:05
04/25/19
04/25
14:05
04/25/19
14:05
Options
Capri Holdings call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

14:00
04/25/19
04/25
14:00
04/25/19
14:00
General news
Treasury Action: the market has eroded slightly »

Treasury Action: the…

CLB

Core Laboratories

$66.31

-6.595 (-9.05%)

13:51
04/25/19
04/25
13:51
04/25/19
13:51
Recommendations
Core Laboratories analyst commentary at Stifel »

Core Laboratories…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 30

    Apr

  • 01

    May

AVP

Avon Products

$3.13

0.175 (5.92%)

13:49
04/25/19
04/25
13:49
04/25/19
13:49
Periodicals
Natura said to be in advanced talks to acquire Avon, Valor Economico says »

Natura is in advanced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

  • 16

    May

DLPH

Delphi Technologies

$22.60

-2 (-8.13%)

13:45
04/25/19
04/25
13:45
04/25/19
13:45
Options
Delphi call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

ADTN

Adtran

$17.39

-0.38 (-2.14%)

13:40
04/25/19
04/25
13:40
04/25/19
13:40
Earnings
Adtran VP Roger Shannon sold over $100K in company shares »

Adtran VP Roger Shannon…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    May

  • 08

    May

AVYA

Avaya

$20.22

0.895 (4.63%)

13:34
04/25/19
04/25
13:34
04/25/19
13:34
Periodicals
Mitel offering to combine with Avaya in stock deal worth over $2B, WSJ says »

Avaya is in talks to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    May

TECK.B

Teck Corp.

$0.00

(0.00%)

13:34
04/25/19
04/25
13:34
04/25/19
13:34
Conference/Events
Teck Corp. management to meet with B.Riley FBR »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Apr

CWT

California Water Service

$49.43

-0.57 (-1.14%)

13:32
04/25/19
04/25
13:32
04/25/19
13:32
Upgrade
California Water Service rating change  »

California Water Service…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

BHC

Bausch Health

$23.18

0.16 (0.70%)

13:30
04/25/19
04/25
13:30
04/25/19
13:30
Hot Stocks
Breaking Hot Stocks news story on Bausch Health »

Bausch Health trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    May

  • 06

    May

  • 06

    May

AVYA

Avaya

$20.20

0.875 (4.53%)

13:28
04/25/19
04/25
13:28
04/25/19
13:28
Periodicals
Mitel offers to combine with Avaya in stock deal, WSJ says »

Mitel's bid values…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    May

CLVS

Clovis

$19.43

-0.4 (-2.02%)

13:25
04/25/19
04/25
13:25
04/25/19
13:25
Options
Clovis call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    May

  • 31

    May

AGN

Allergan

$140.66

0.98 (0.70%)

, TEVA

Teva

$15.07

0.065 (0.43%)

13:25
04/25/19
04/25
13:25
04/25/19
13:25
Conference/Events
Piper Jaffray specialty pharma analysts to hold analyst/industry conference call »

Specialty Pharmaceuticals…

AGN

Allergan

$140.66

0.98 (0.70%)

TEVA

Teva

$15.07

0.065 (0.43%)

ALDR

Alder Biopharmaceuticals

$13.95

0.29 (2.12%)

AMGN

Amgen

$179.82

1.56 (0.88%)

BHVN

Biohaven Pharmaceutical

$62.30

-0.855 (-1.35%)

LLY

Eli Lilly

$117.99

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 28

    Apr

  • 28

    Apr

  • 30

    Apr

  • 30

    Apr

  • 02

    May

  • 03

    May

  • 04

    May

  • 06

    May

  • 07

    May

  • 07

    May

  • 08

    May

  • 09

    May

  • 18

    May

  • 21

    May

  • 29

    May

  • 31

    May

  • 05

    Jun

ZM

Zoom Video

$64.49

1.175 (1.86%)

13:21
04/25/19
04/25
13:21
04/25/19
13:21
Hot Stocks
Zoom, Slack announce new partnership »

Zoom and Slack have…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BHC

Bausch Health

$23.18

0.16 (0.70%)

13:21
04/25/19
04/25
13:21
04/25/19
13:21
Hot Stocks
Bausch Health announces FDA approval of Duobrii for plaque psoriasis »

Bausch Health and its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    May

  • 06

    May

  • 06

    May

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

13:17
04/25/19
04/25
13:17
04/25/19
13:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

13:16
04/25/19
04/25
13:16
04/25/19
13:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BA

Boeing

$382.62

7.3 (1.95%)

13:16
04/25/19
04/25
13:16
04/25/19
13:16
Recommendations
Boeing analyst commentary at Bernstein »

Bernstein says Aviation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Apr

  • 29

    May

  • 05

    Jun

BA

Boeing

$382.62

7.3 (1.95%)

13:15
04/25/19
04/25
13:15
04/25/19
13:15
Periodicals
FAA targeting May 23 for meeting over 737 MAX changes, Aviation Week says »

The FAA is targeting May…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Apr

  • 29

    May

  • 05

    Jun

13:12
04/25/19
04/25
13:12
04/25/19
13:12
General news
7-Yr Note Auction Coupon Rate data reported »

7-Yr Note Auction Coupon…

13:12
04/25/19
04/25
13:12
04/25/19
13:12
General news
7-Yr Note Auction Total Amount data reported »

7-Yr Note Auction Total…

RSG

Republic Services

$79.29

-0.01 (-0.01%)

13:10
04/25/19
04/25
13:10
04/25/19
13:10
Options
Upside call buys in Republic Services ahead of earnings »

Upside call buys in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 05

    May

  • 17

    May

  • 05

    Jun

LUV

Southwest

$54.00

1.08 (2.04%)

13:06
04/25/19
04/25
13:06
04/25/19
13:06
Hot Stocks
Breaking Hot Stocks news story on Southwest »

Southwest continues to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 15

    May

  • 21

    May

  • 13

    Nov

LUV

Southwest

$54.00

1.08 (2.04%)

, BA

Boeing

$379.25

3.93 (1.05%)

13:06
04/25/19
04/25
13:06
04/25/19
13:06
Hot Stocks
Southwest expects FY19 capacity to increase 2%-3% y-o-y »

Says continues to have…

LUV

Southwest

$54.00

1.08 (2.04%)

BA

Boeing

$379.25

3.93 (1.05%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 29

    Apr

  • 15

    May

  • 21

    May

  • 29

    May

  • 05

    Jun

  • 13

    Nov

BUD

AB InBev

$86.38

-1.82 (-2.06%)

13:05
04/25/19
04/25
13:05
04/25/19
13:05
Options
Anheuser Busch call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 07

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.